124 related articles for article (PubMed ID: 18060765)
21. Concept of a selective tumour therapy and its evaluation by near-infrared fluorescence imaging and flat-panel volume computed tomography in mice.
Alves F; Dullin C; Napp J; Missbach-Guentner J; Jannasch K; Mathejczyk J; Pardo LA; Stühmer W; Tietze LF
Eur J Radiol; 2009 May; 70(2):286-93. PubMed ID: 19285818
[TBL] [Abstract][Full Text] [Related]
22. Multimodal imaging approaches: PET/CT and PET/MRI.
Pichler BJ; Judenhofer MS; Pfannenberg C
Handb Exp Pharmacol; 2008; (185 Pt 1):109-32. PubMed ID: 18626801
[TBL] [Abstract][Full Text] [Related]
23. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
24. Molecular imaging in cancer.
Weissleder R
Science; 2006 May; 312(5777):1168-71. PubMed ID: 16728630
[TBL] [Abstract][Full Text] [Related]
25. MR in oncology drug development.
Galbraith SM
NMR Biomed; 2006 Oct; 19(6):681-9. PubMed ID: 16986117
[TBL] [Abstract][Full Text] [Related]
26. PET/CT for the staging and follow-up of patients with malignancies.
Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
[TBL] [Abstract][Full Text] [Related]
27. Imaging tumour-bearing animals using clinical scanners.
Wolf G; Abolmaali N
Int J Radiat Biol; 2009 Sep; 85(9):752-62. PubMed ID: 19479601
[TBL] [Abstract][Full Text] [Related]
28. [Measurement of tumour response to cancer treatment: morphologic imaging role].
Ollivier L; Leclère J; Thiesse P; Di Stefano D; Vincent C
Bull Cancer; 2007 Feb; 94(2):171-7. PubMed ID: 17337386
[TBL] [Abstract][Full Text] [Related]
29. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
30. Noninvasive assessment of coronary anatomy and myocardial perfusion: going toward an integrated imaging approach.
Petretta M; Costanzo P; Acampa W; Imbriaco M; Ferro A; Filardi PP; Cuocolo A
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):977-86. PubMed ID: 18799959
[TBL] [Abstract][Full Text] [Related]
31. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
32. 2-Methoxyestradiol--a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents.
Sutherland TE; Anderson RL; Hughes RA; Altmann E; Schuliga M; Ziogas J; Stewart AG
Drug Discov Today; 2007 Jul; 12(13-14):577-84. PubMed ID: 17631253
[TBL] [Abstract][Full Text] [Related]
33. Molecular imaging of apoptosis in cancer.
Hakumäki JM; Liimatainen T
Eur J Radiol; 2005 Nov; 56(2):143-53. PubMed ID: 15885960
[TBL] [Abstract][Full Text] [Related]
34. Molecular imaging of novel cell- and viral-based therapies.
Schellingerhout D
Neuroimaging Clin N Am; 2006 Nov; 16(4):655-79, ix. PubMed ID: 17148025
[TBL] [Abstract][Full Text] [Related]
35. Molecular imaging can accelerate anti-angiogenic drug development and testing.
Iagaru A; Chen X; Gambhir SS
Nat Clin Pract Oncol; 2007 Oct; 4(10):556-7. PubMed ID: 17726490
[No Abstract] [Full Text] [Related]
36. Image-based evaluation of tumor response to treatment: where is radiology today?
Kharuzhyk S; Fabel M; von Tengg-Kobligk H; Kauczor HU
Exp Oncol; 2008 Sep; 30(3):181-9. PubMed ID: 18806739
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of tumour response to treatment with targeted therapies: standard or targeted criteria?].
Menu Y
Bull Cancer; 2007; 94(7 Suppl):F231-9. PubMed ID: 17965002
[TBL] [Abstract][Full Text] [Related]
38. [Consideration on response evaluation criteria in molecular targeting therapy].
Yü SY
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):556-8. PubMed ID: 19062730
[No Abstract] [Full Text] [Related]
39. Functional imaging in drug discovery and development. 30 September-1 October 1999, Paris, France.
Wiebe LI
IDrugs; 1999 Dec; 2(12):1289-91. PubMed ID: 16113960
[TBL] [Abstract][Full Text] [Related]
40. A radiologist's guide to treatment response criteria in oncologic imaging: functional, molecular, and disease-specific imaging biomarkers.
Rezai P; Pisaneschi MJ; Feng C; Yaghmai V
AJR Am J Roentgenol; 2013 Aug; 201(2):246-56. PubMed ID: 23883206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
